NCT00559312View on ClinicalTrials.gov

The Effect of Fluticasone/Salmeterol Combination on Exertional Breathlessness in Patients With Mild COPD

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

March 31, 2010

Study Completion Date

April 30, 2010

Conditions
COPD
Interventions
DRUG

fluticasone/salmeterol combination

Diskus inhaler, fluticasone 250μg/salmeterol 50μg, twice daily, 6-week duration

DRUG

placebo

Placebo Diskus inhaler, twice daily, 6-week duration

Trial Locations (1)

K7L 2V7

Respiratory Investigation Unit at Kingston General Hospital, Kingston

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Queen's University

OTHER